BNP Paribas Knock-Out DVA/ DE000PC6W1Z1 /
5/17/2024 9:20:31 PM | Chg.-0.300 | Bid9:32:17 PM | Ask9:32:17 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.100EUR | -21.43% | 1.100 Bid Size: 23,100 |
1.130 Ask Size: 23,100 |
DaVita Inc | 150.3189 USD | 12/31/2078 | Put |
GlobeNewswire
4/26
Benevity’s 2024 Corporate Goodness Awards Celebrate Groundbreakers in Social Impact
GlobeNewswire
11/17/2023
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial pres...
GlobeNewswire
8/15/2023
Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development
GlobeNewswire
3/21/2022
Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire
3/7/2022
The Oncology Institute Announces Promotions for Dr. Daniel Virnich and Dr. Matt Miller
GlobeNewswire
2/10/2022
Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022
GlobeNewswire
10/7/2021
Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Anima...
GlobeNewswire
10/1/2021
AAON Increases Board Size and Appoints Bruce Ware and David Stewart as Independent Directors
GlobeNewswire
9/9/2021
ACTION BEHAVIOR CENTERS HIRES NEW GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
GlobeNewswire
9/9/2021
Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development